Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

nab-paclitaxel

View Patient Information
A Cremophor EL-free, albumin-stabilized nanoparticle formulation of the natural taxane paclitaxel with antineoplastic activity. Paclitaxel binds to and stabilizes microtubules, preventing their depolymerization and so inhibiting cellular motility, mitosis, and replication. This formulation solubilizes paclitaxel without the use of the solvent Cremophor, thereby permitting the administration of larger doses of paclitaxel while avoiding the toxic effects associated with Cremophor.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:albumin-bound paclitaxel
albumin-stabilized nanoparticle paclitaxel
nab paclitaxel
nanoparticle albumin-bound paclitaxel
nanoparticle paclitaxel
paclitaxel albumin
paclitaxel protein-bound
protein-bound paclitaxel
US brand name:Abraxane
Code name:ABI 007
ABI-007
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search